SNDX
Syndax Pharmaceuticals, Inc. · Healthcare
Director Dennis Podlesak sold $1.9M of Syndax Pharmaceuticals, Inc.
Sold$1,897,988
$24.08Price
78,815Shares
−51%Stake
What SNDX did after the filing
- The stock from Fri, Sep 16 close, $23.14
- +2.5%
- S&P 500, same days
- +0.9%
Measured over 30 trading days, to the Oct 28 close.
Traded Thu, Sep 15. Filed Fri, Sep 16, 1:34 PM ET, during the session. Returns use the Sep 16 close and the Oct 28 close. Not investment advice.